147 related articles for article (PubMed ID: 12767550)
1. Lipid profiles and endothelial function with low-dose hormone replacement therapy in postmenopausal women at risk for coronary artery disease: a randomized trial.
Mercuro G; Vitale C; Fini M; Zoncu S; Leonardo F; Rosano GM
Int J Cardiol; 2003 Jun; 89(2-3):257-65. PubMed ID: 12767550
[TBL] [Abstract][Full Text] [Related]
2. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
[TBL] [Abstract][Full Text] [Related]
3. Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women.
Koh KK; Shin MS; Sakuma I; Ahn JY; Jin DK; Kim HS; Kim DS; Han SH; Chung WJ; Shin EK
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1516-21. PubMed ID: 15166013
[TBL] [Abstract][Full Text] [Related]
4. Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen.
Wakatsuki A; Okatani Y; Ikenoue N; Fukaya T
Circulation; 2001 Oct; 104(15):1773-8. PubMed ID: 11591613
[TBL] [Abstract][Full Text] [Related]
5. Effect of lower dosage of oral conjugated equine estrogen on inflammatory markers and endothelial function in healthy postmenopausal women.
Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):571-6. PubMed ID: 14699021
[TBL] [Abstract][Full Text] [Related]
6. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
[TBL] [Abstract][Full Text] [Related]
7. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
8. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.
Silvestri A; Gambacciani M; Vitale C; Monteleone P; Ciaponi M; Fini M; Genazzani AR; Mercuro G; Rosano GM
Maturitas; 2005 Apr; 50(4):305-11. PubMed ID: 15780531
[TBL] [Abstract][Full Text] [Related]
9. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
[TBL] [Abstract][Full Text] [Related]
10. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and lipid-lipoprotein concentrations.
Gökmen O; Yapar Eyi EG
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
[TBL] [Abstract][Full Text] [Related]
12. Does the beneficial effect of HRT on endothelial function depend on lipid changes.
Ossewaarde ME; Bots ML; van der Schouw YT; de Kleijn MJ; Wilmink HW; Bak AA; Planellas J; Banga JD; Grobbee DE
Maturitas; 2003 May; 45(1):47-54. PubMed ID: 12753943
[TBL] [Abstract][Full Text] [Related]
13. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
Walsh BW; Kuller LH; Wild RA; Paul S; Farmer M; Lawrence JB; Shah AS; Anderson PW
JAMA; 1998 May; 279(18):1445-51. PubMed ID: 9600478
[TBL] [Abstract][Full Text] [Related]
14. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
[TBL] [Abstract][Full Text] [Related]
15. Effects of withdrawal of chronic estrogen therapy on brachial artery vasoreactivity in women with coronary artery disease.
Greiner DZ; Personius BE; Andrews TC
Am J Cardiol; 1999 Jan; 83(2):247-9, A5. PubMed ID: 10073827
[TBL] [Abstract][Full Text] [Related]
16. Flow resistance in carotid and middle cerebral arteries in postmenopausal women: a comparative study of tibolone and continuous combined hormone replacement therapy.
Pan HA; Wang ST; Chen CH; Pai MC; Wu MH; Huang KE
Climacteric; 2002 Sep; 5(3):259-65. PubMed ID: 12419084
[TBL] [Abstract][Full Text] [Related]
17. The independent effects of exercise and estrogen on lipids and lipoproteins in postmenopausal women.
Lindheim SR; Notelovitz M; Feldman EB; Larsen S; Khan FY; Lobo RA
Obstet Gynecol; 1994 Feb; 83(2):167-72. PubMed ID: 8290176
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen and medroxyprogesterone acetate on subpopulations of triglyceride-rich lipoproteins and high-density lipoproteins.
Lamon-Fava S; Posfai B; Asztalos BF; Horvath KV; Dallal GE; Schaefer EJ
Metabolism; 2003 Oct; 52(10):1330-6. PubMed ID: 14564686
[TBL] [Abstract][Full Text] [Related]
19. Effects of estrogen replacement with and without medroxyprogesterone acetate on brachial flow-mediated vasodilator responses in postmenopausal women with coronary artery disease.
Yeboah J; Reboussin DM; Waters D; Kowalchuk G; Herrington DM
Am Heart J; 2007 Mar; 153(3):439-44. PubMed ID: 17307425
[TBL] [Abstract][Full Text] [Related]
20. Overweight and effect of hormone replacement therapy on lipid profiles in postmenopausal women.
Ko HS; Kim CJ; Ryu WS
Korean J Intern Med; 2005 Mar; 20(1):33-9. PubMed ID: 15906951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
